UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended
December 31, 2013
 
Commission File Number 001-34974
 
 
 

 
AEROFLEX HOLDING CORP.
 
(Exact name of Registrant as specified in its Charter)
 
DELAWARE
01-0899019
(State or other jurisdiction
(I.R.S. Employer
of incorporation or organization)
Identification No.)
 
35 South Service Road
 
P.O. Box 6022
 
Plainview, N.Y.
11803-0622
(Address of principal executive offices)
 (Zip Code)
 
(516) 694-6700
(Registrant’s telephone number, including area code)
 

 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x          No ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x    No ¨
   
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):
 
 
Large accelerated filer ¨
Accelerated filer x
 
Non-accelerated filer ¨
Smaller reporting company ¨
 
(Do not check if a smaller reporting company)
 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 Yes ¨   No x
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.
   
February 7, 2014
 
85,208,482 
(Date)
 
(Number of Shares)
 
 
 
AEROFLEX HOLDING CORP.
AND SUBSIDIARIES
INDEX
 
 
PART I:        FINANCIAL INFORMATION
PAGE
 
 
 
Item 1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
 
December 31, 2013 and June 30, 2013 
 
 
 
 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
 
Three Months Ended December 31, 2013 and 2012
3
 
Six Months Ended December 31, 2013 and 2012
4
 
 
 
 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
 
 
Three Months Ended December 31, 2013 and 2012
5
 
Six Months Ended December 31, 2013 and 2012
5
 
 
 
 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
Six Months Ended December 31, 2013 and 2012
6
 
 
 
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
7 – 16
 
 
 
Item 2
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
 
Three and Six Months Ended December 31, 2013 and 2012
17 – 28
 
 
 
Item 3
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
29
 
 
 
Item 4
CONTROLS AND PROCEDURES
29
 
 
 
 
PART II:          OTHER INFORMATION
 
 
 
 
Item 1
LEGAL PROCEEDINGS
30
 
 
 
Item 1A
RISK FACTORS
30
 
 
 
Item 2
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
30
 
 
 
Item 3
DEFAULTS UPON SENIOR SECURITIES
30
 
 
 
Item 4
MINE SAFETY DISCLOSURES
30
 
 
 
Item 5
OTHER INFORMATION
30
 
 
 
Item 6
EXHIBITS
30
 
 
 
SIGNATURE
31
 
 
EXHIBIT INDEX
32
 
 
CERTIFICATIONS
 
 
1

 
Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(In thousands, except share and per share data)
 
 
 
December 31,
 
June 30,
 
 
 
2013
 
2013
 
Assets
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
60,949
 
$
39,424
 
Accounts receivable, less allowance for doubtful accounts of $3,453 and $3,422
 
 
125,417
 
 
151,163
 
Inventories
 
 
170,146
 
 
156,516
 
Deferred income taxes
 
 
34,496
 
 
35,491
 
Prepaid expenses and other current assets
 
 
14,107
 
 
9,374
 
Total current assets
 
 
405,115
 
 
391,968
 
 
 
 
 
 
 
 
 
Property, plant and equipment, net of accumulated depreciation of $121,091 and $122,479
 
 
100,982
 
 
101,546
 
Deferred financing costs, net
 
 
10,722
 
 
11,580
 
Other assets
 
 
31,188
 
 
31,886
 
Intangible assets with definite lives, net
 
 
48,676
 
 
65,552
 
Intangible assets with indefinite lives
 
 
113,006
 
 
110,779
 
Goodwill
 
 
316,990
 
 
315,643
 
 
 
 
 
 
 
 
 
Total assets
 
$
1,026,679
 
$
1,028,954
 
 
 
 
 
 
 
 
 
Liabilities and Stockholders' Equity
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
Accounts payable
 
$
29,174
 
$
34,768
 
Advance payments by customers and deferred revenue
 
 
23,280
 
 
23,490
 
Income taxes payable
 
 
3,086
 
 
12,003
 
Accrued payroll expenses
 
 
17,655
 
 
21,694
 
Accrued expenses and other current liabilities
 
 
34,642
 
 
37,184
 
Total current liabilities
 
 
107,837
 
 
129,139
 
 
 
 
 
 
 
 
 
Long-term debt
 
 
587,000
 
 
587,000
 
Deferred income taxes
 
 
62,459
 
 
67,296
 
Other long-term liabilities
 
 
20,262
 
 
23,061
 
Total liabilities
 
 
777,558
 
 
806,496
 
 
 
 
 
 
 
 
 
Stockholders' equity:
 
 
 
 
 
 
 
Preferred stock, par value $.01 per share; 50,000,000 shares authorized, no shares
    issued and outstanding
 
 
-
 
 
-
 
Common stock, par value $.01 per share; 300,000,000 shares authorized, 85,208,482
    and 84,936,582 shares issued and outstanding
 
 
852
 
 
849
 
Additional paid-in capital
 
 
652,175
 
 
651,950
 
Accumulated other comprehensive income (loss)
 
 
(28,605)
 
 
(43,406)
 
Accumulated deficit
 
 
(375,301)
 
 
(386,935)
 
Total stockholders' equity
 
 
249,121
 
 
222,458
 
 
 
 
 
 
 
 
 
Total liabilities and stockholders' equity
 
$
1,026,679
 
$
1,028,954
 
 
See notes to unaudited condensed consolidated financial statements.
 
 
2

 
Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(In thousands, except per share data)
 
 
 
Three Months Ended December 31,
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Net sales
 
$
151,105
 
$
151,872
 
Cost of sales
 
 
76,125
 
 
73,814
 
Gross profit
 
 
74,980
 
 
78,058
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
Selling, general and administrative costs
 
 
34,012
 
 
36,427
 
Research and development costs
 
 
22,694
 
 
21,088
 
Amortization of acquired intangibles
 
 
7,212
 
 
14,063
 
Restructuring charges
 
 
1,539
 
 
66
 
Impairment of asset held for sale
 
 
-
 
 
1,340
 
Total operating expenses
 
 
65,457
 
 
72,984
 
Operating income
 
 
9,523
 
 
5,074
 
 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
Interest expense
 
 
(7,240)
 
 
(9,768)
 
Write-off of deferred financing costs
 
 
-
 
 
(227)
 
Other income (expense), net
 
 
(296)
 
 
(212)
 
Total other income (expense), net
 
 
(7,536)
 
 
(10,207)
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations before income taxes
 
 
1,987
 
 
(5,133)
 
Provision (benefit) for income taxes
 
 
860
 
 
(5,306)
 
Income from continuing operations
 
 
1,127
 
 
173
 
 
 
 
 
 
 
 
 
Discontinued operations:
 
 
 
 
 
 
 
Income from discontinued operations, net of tax provision of $178
 
 
-
 
 
572
 
 
 
 
 
 
 
 
 
Net income
 
$
1,127
 
$
745
 
 
 
 
 
 
 
 
 
Income per common share - basic:
 
 
 
 
 
 
 
Continuing operations
 
$
0.01
 
$
-
 
Discontinued operations
 
 
-
 
 
0.01
 
Net income
 
$
0.01
 
$
0.01
 
Income per common share - diluted:
 
 
 
 
 
 
 
Continuing operations
 
$
0.01
 
$
-
 
Discontinued operations
 
 
-
 
 
0.01
 
Net income
 
$
0.01
 
$
0.01
 
 
 
 
 
 
 
 
 
Weighted average number of common shares outstanding:
 
 
 
 
 
 
 
Basic
 
 
85,014
 
 
84,870
 
Diluted
 
 
85,223
 
 
84,880
 
 
See notes to unaudited condensed consolidated financial statements.
 
 
3

 
Aeroflex Holding Corp. and Subsidiaries
Unaudited Condensed Consolidated Statements of Operations
(In thousands, except per share data)
 
 
 
Six Months Ended December 31,
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Net sales
 
$
283,837
 
$
289,507
 
Cost of sales
 
 
143,039
 
 
143,227
 
Gross profit
 
 
140,798
 
 
146,280
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
Selling, general and administrative costs
 
 
67,180
 
 
71,947
 
Research and development costs
 
 
44,179
 
 
41,966
 
Amortization of acquired intangibles
 
 
17,730
 
 
28,643
 
Restructuring charges
 
 
2,223
 
 
3,333
 
Impairment of asset held for sale
 
 
-
 
 
1,340
 
Total operating expenses
 
 
131,312
 
 
147,229
 
Operating income (loss)
 
 
9,486
 
 
(949)
 
 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
Interest expense
 
 
(14,492)
 
 
(19,846)
 
Write-off of deferred financing costs
 
 
-
 
 
(824)
 
Other income (expense), net
 
 
(347)
 
 
(501)
 
Total other income (expense), net
 
 
(14,839)
 
 
(21,171)
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations before income taxes
 
 
(5,353)
 
 
(22,120)
 
Provision (benefit) for income taxes
 
 
(2,525)
 
 
(7,777)
 
Income (loss) from continuing operations
 
 
(2,828)
 
 
(14,343)
 
 
 
 
 
 
 
 
 
Discontinued operations:
 
 
 
 
 
 
 
Income from discontinued operations, net of tax provision of $105 and $295
 
 
360
 
 
949
 
Gain on disposal of operations, net of tax of $0
 
 
14,102
 
 
-
 
Income from discontinued operations
 
 
14,462
 
 
949
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
11,634
 
$
(13,394)
 
 
 
 
 
 
 
 
 
Income (loss) per common share - basic and diluted:
 
 
 
 
 
 
 
Continuing operations
 
$
(0.03)
 
$
(0.17)
 
Discontinued operations
 
 
0.17
 
 
0.01
 
Net income (loss)
 
$
0.14
 
$
(0.16)
 
 
 
 
 
 
 
 
 
Weighted average number of common shares outstanding:
 
 
 
 
 
 
 
Basic and diluted
 
 
84,965
 
 
84,853
 
 
See notes to unaudited condensed consolidated financial statements.
 
 
4

 
Aeroflex Holding Corp. and Subsidiaries
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)
 (In thousands)
 
 
 
Three Months Ended December 31,
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
1,127
 
$
745
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
Minimum pension liability adjustment, net of tax provision (benefit) of $21
 
 
25
 
 
-
 
Foreign currency translation adjustment, net of tax provision (benefit) of $162 and $37
 
 
4,201
 
 
793
 
 
 
 
4,226
 
 
793
 
 
 
 
 
 
 
 
 
Total comprehensive income (loss)
 
$
5,353
 
$
1,538
 
 
 
 
Six Months Ended December 31,
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
11,634
 
$
(13,394)
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
Minimum pension liability adjustment, net of tax provision (benefit) of $42
 
 
50
 
 
-
 
Foreign currency translation adjustment, net of tax provision (benefit) of $572 and $229
 
 
14,751
 
 
6,270
 
 
 
 
14,801
 
 
6,270
 
 
 
 
 
 
 
 
 
Total comprehensive income (loss)
 
$
26,435
 
$
(7,124)
 
 
See notes to unaudited condensed consolidated financial statements.
 
 
5

 
Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(In thousands)
 
 
 
Six Months Ended December 31,
 
 
 
2013
 
2012
 
Cash flows from operating activities:
 
 
 
 
 
 
 
Net income (loss)
 
$
11,634
 
$
(13,394)
 
Adjustments to reconcile net income (loss) to net cash provided by (used in)
 
 
 
 
 
 
 
operating activities:
 
 
 
 
 
 
 
Depreciation and amortization
 
 
29,762
 
 
39,803
 
Gain on disposal of operations
 
 
(14,102)
 
 
-
 
Impairment of asset held for sale
 
 
-
 
 
1,340
 
Write-off of deferred financing costs
 
 
-
 
 
824
 
Deferred income taxes
 
 
(6,208)
 
 
(7,766)
 
Share-based compensation
 
 
2,012
 
 
1,367
 
Amortization of deferred financing costs
 
 
858
 
 
1,101
 
Other, net
 
 
208
 
 
774
 
Change in operating assets and liabilities, net of effects from sale of business:
 
 
 
 
 
 
 
Decrease (increase) in accounts receivable
 
 
23,864
 
 
20,404
 
Decrease (increase) in inventories
 
 
(11,728)
 
 
(1,342)
 
Decrease (increase) in prepaid expenses and other assets
 
 
(2,964)
 
 
3,676
 
Increase (decrease) in accounts payable, accrued expenses and other liabilities
 
 
(23,292)
 
 
(2,678)
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
 
10,044
 
 
44,109
 
 
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
 
Net proceeds from the sale of business
 
 
18,389
 
 
-
 
Capital expenditures
 
 
(9,665)
 
 
(9,262)
 
Other, net
 
 
126
 
 
335
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) investing activities
 
 
8,850
 
 
(8,927)
 
 
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
 
Debt repayments
 
 
-
 
 
(35,000)
 
Other, net
 
 
(1,757)
 
 
(641)
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) financing activities
 
 
(1,757)
 
 
(35,641)
 
 
 
 
 
 
 
 
 
Effect of exchange rate changes on cash and cash equivalents
 
 
4,388
 
 
811
 
 
 
 
 
 
 
 
 
Net increase (decrease) in cash and cash equivalents
 
 
21,525
 
 
352
 
Cash and cash equivalents at beginning of period
 
 
39,424
 
 
41,324
 
 
 
 
 
 
 
 
 
Cash and cash equivalents at end of period
 
$
60,949
 
$
41,676
 
 
See notes to unaudited condensed consolidated financial statements. 
 
 
6

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 
1.     Basis of Presentation
 
The accompanying unaudited condensed consolidated financial information of Aeroflex Holding Corp. and subsidiaries (“we”, “our”, “us”, or the “Company”) has been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”), and reflects all adjustments, consisting of normal recurring adjustments, which in management’s opinion are necessary for a fair presentation. The June 30, 2013 balance sheet information has been derived from audited financial statements, but does not include all information or disclosures required by U.S. GAAP.
 
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of sales and expenses during the reporting period. Actual results may differ from those estimates, and such differences may be material to the financial statements.
 
These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in our annual report on Form 10-K for the fiscal year ended June 30, 2013 (“the fiscal 2013 Form 10-K”).
 
Unless the context requires otherwise, “fiscal” refers to the twelve months ended June 30 of the applicable year.  For example, “fiscal 2013” refers to the twelve months ended June 30, 2013.
 
Results of operations for interim periods are not necessarily indicative of results to be expected for the full fiscal year or any future periods.

2.
Recent Accounting Pronouncements
 
In February 2013, the FASB issued guidance which improves the reporting of reclassifications out of accumulated other comprehensive income. The new guidance requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. GAAP to be reclassified in its entirety to net income. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety from accumulated other comprehensive income to net income in the same reporting period, an entity is required to cross-reference other disclosures required under U.S. GAAP that provide additional detail about those amounts. This new guidance became effective for us in our first quarter of fiscal 2014. The adoption of this presentation and disclosure only guidance is reflected in our consolidated financial statements.
 
In March 2013, the FASB issued authoritative guidance to resolve the diversity in practice concerning the release of the cumulative translation adjustment (“CTA”) into net income (i) when a parent sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets within a foreign entity, and (ii) in connection with a step acquisition of a foreign entity. This amended guidance requires that CTA be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided, and that a pro rata portion of the CTA be released into net income upon a partial sale of an equity method investment in a foreign entity only. In addition, the amended guidance clarifies the definition of a sale of an investment in a foreign entity to include both events that result in the loss of a controlling financial interest in a foreign entity and events that result in an acquirer obtaining control of an acquiree in which it held an equity interest immediately prior to the date of acquisition. The CTA should be released into net income upon the occurrence of such events. This new guidance becomes effective prospectively for us in our first quarter of fiscal 2015. The adoption of this new guidance is not expected to have a significant impact on our consolidated financial statements. 
 
 
7

 
In July 2013, the FASB issued guidance that clarifies when an entity should present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. If either (i) a net operating loss carryforward, a similar tax loss, or tax credit carryforward is not available as of the reporting date under the governing tax law to settle taxes that would result from the disallowance of the tax position or (ii) the entity does not intend to use the deferred tax asset for this purpose (provided that the tax law permits a choice), an entity should present an unrecognized tax benefit in the financial statements as a liability and should not net the unrecognized tax benefit with a deferred tax asset. This new guidance becomes effective prospectively for us in our first quarter of fiscal 2015, with retrospective application and early adoption permitted. The adoption of this new guidance is not expected to have a significant impact on our consolidated financial statements.

3.
Discontinued Operations
 
On September 5, 2013, we sold the net assets of Aeroflex Test Equipment Services (“ATES”), a division of our U.K. subsidiary, Aeroflex Limited, for $18.4 million in cash. The consideration is subject to a working capital adjustment, based on the amount by which the final working capital at the date of closing differed from the target set forth in the purchase agreement. ATES provided calibration and repair services of non-Aeroflex test and measurement equipment in the United Kingdom and was previously included in our Aeroflex Test Solutions (“ATS”) segment. As a result of this sale, we recorded a gain on disposal of $14.1 million. The gain is not subject to U.K. taxes.
 
We have reported the results of operations of ATES as income from discontinued operations. The prior period statement of operations has been restated to conform to the current presentation. Net sales from the ATES operations were $2.4 million from July 1, 2013 to the date of sale and $4.4 million and $7.9 million for the three and six months ended December 31, 2012, respectively.

4.
Inventories
 
Inventories consisted of the following:
 
 
 
December 31,
 
June 30,
 
 
 
2013
 
2013
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
Raw materials
 
$
83,835
 
$
76,762
 
Work in process
 
 
52,317
 
 
52,221
 
Finished goods
 
 
33,994
 
 
27,533
 
 
 
$
170,146
 
$
156,516
 
 
 
8

 
5.     Intangible Assets and Other Long Lived Assets
 
Intangible Assets with Definite Lives
 
The components of amortizable intangible assets were as follows:
 
 
 
December 31, 2013
 
June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross
 
 
 
 
 
 
 
Gross
 
 
 
 
 
 
 
 
 
Carrying
 
Accumulated
 
Total Net
 
Carrying
 
Accumulated
 
Total Net
 
 
 
Amount
 
Amortization
 
Book Value
 
Amount
 
Amortization
 
Book Value
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Developed technology
 
$
204,368
 
$
199,409
 
$
4,959
 
$
201,447
 
$
192,574
 
$
8,873
 
Customer related intangibles
 
 
227,970
 
 
185,338
 
 
42,632
 
 
226,406
 
 
171,514
 
 
54,892
 
Non-compete arrangements
 
 
10,420
 
 
10,023
 
 
397
 
 
10,344
 
 
9,401
 
 
943
 
Trade names
 
 
3,382
 
 
2,694
 
 
688
 
 
3,332
 
 
2,488
 
 
844
 
Total
 
$
446,140
 
$
397,464
 
$
48,676
 
$
441,529
 
$
375,977
 
$
65,552
 
 
Goodwill
 
We assess goodwill and other intangible assets with indefinite lives at least annually for impairment, in the fourth quarter of our fiscal year, or more frequently if certain events or circumstances indicate an impairment may have occurred. We test goodwill for impairment at the reporting unit level, which is one level below our operating segments.
 
The carrying amount of goodwill, by segment, was as follows:
 
 
 
Microelectronic
 
Test
 
 
 
 
 
 
Solutions
 
Solutions
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
Balance at June 30, 2013
 
 
 
 
 
 
 
 
 
 
Goodwill
 
$
339,859
 
$
159,284
 
$
499,143
 
Accumulated impairments
 
 
(90,100)
 
 
(93,400)
 
 
(183,500)
 
 
 
 
249,759
 
 
65,884
 
 
315,643
 
 
 
 
 
 
 
 
 
 
 
 
Changes for the six months ended December 31, 2013
 
 
 
 
 
 
 
 
 
 
Translation and other adjustments
 
 
759
 
 
588
 
 
1,347
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2013
 
 
 
 
 
 
 
 
 
 
Goodwill
 
 
340,618
 
 
159,872
 
 
500,490
 
Accumulated impairments
 
 
(90,100)
 
 
(93,400)
 
 
(183,500)
 
 
 
$
250,518
 
$
66,472
 
$
316,990
 
 
Based on a reduced forecast in one of our ATS reporting units, Avionics-Communications (“AVComm”), resulting from continued uncertainty in government spending, we have tested this reporting unit for impairment. As of December 31, 2013, the AVComm group had goodwill of $24.1 million and an enterprise carrying value of $91.2 million. We evaluated if there was impairment by comparing the fair value of the reporting unit with its enterprise carrying value. Based on our current analysis of the discounted estimated cash flows of this group, we have estimated that the fair value of this group was approximately $98.6 million at December 31, 2013 and that the goodwill has not been impaired. However, should actual results differ from our forecasts of cash flows and our estimated enterprise fair value decreases below the carrying value, then an impairment would likely occur and we would need to calculate the amount of the write-down of goodwill by comparing the implied fair value of the reporting unit’s goodwill (the excess of the fair value of the reporting unit over the fair value of its net identifiable assets) with the carrying amount of that goodwill.
 
 
9

 
Other Long Lived Assets
 
In December 2012, we entered into a contract for the sale of our RF and microwave components (“RFMW”) Whippany, New Jersey building. The net proceeds received in January 2013 were less than the carrying value of the building. Therefore, in December 2012, we recorded a $1.3 million impairment to the asset held for sale. Our RFMW reporting unit is included within our Aeroflex Microelectronic Solutions (“AMS”) segment.

6.     Restructuring Charges
 
The following table sets forth the charges and payments related to the restructuring liability, which is reflected in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheets and primarily relates to our ATS segment for both our Wireless and AVComm groups, for the period indicated:
 
 
 
Balance
 
 
 
 
 
 
 
 
 
 
Balance
 
 
 
June 30,
 
 
 
 
 
 
 
 
 
 
December 31,
 
 
 
2013
 
Six Months Ended December 31, 2013
 
2013
 
 
 
 
 
 
 
 
 
 
 
 
Effect of
 
 
 
 
 
 
Restructuring
 
 
 
 
Cash
 
Foreign
 
Restructuring
 
 
 
Liability
 
Net Additions
 
Payments
 
Currency
 
Liability
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Severance costs
 
$
904
 
$
1,171
 
$
(1,540)
 
$
22
 
$
557
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Facilities closure costs
 
 
88
 
 
1,052
 
 
(1,006)
 
 
-
 
 
134
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
$
992
 
$
2,223
 
$
(2,546)
 
$
22
 
$
691
 
 

7.             Derivative Financial Instruments
 
We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. When deemed appropriate to do so, we enter into interest rate swap derivatives to manage the effects of interest rate movements on portions of our debt. We routinely enter into foreign currency forward contracts, not designated as hedging instruments, to protect us from fluctuations in exchange rates.
 
Foreign Currency Forward Contract Derivatives
 
Foreign currency forward contracts are used to protect us from fluctuations in exchange rates. Our foreign currency forward contracts are not designated as hedges and therefore the change in fair value is included in other income (expense) as it occurs.  As of December 31, 2013, we had $47.8 million of notional value foreign currency forward contracts maturing through January 31, 2014. Notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.
 
 
10

 
The fair values of our derivative financial instruments included in the condensed consolidated balance sheets as of December 31, 2013 and June 30, 2013 were as follows:
 
 
 
Asset (Liability) Derivatives
 
 
 
December 31, 2013
 
June 30, 2013
 
 
 
Balance Sheet
 
 
 
 
Balance Sheet
 
 
 
 
(In thousands)
 
Location
 
Fair Value (1)
 
Location
 
Fair Value (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging
    instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
Prepaid expenses and other current assets
 
$
224
 
Accrued expenses and other current liabilities
 
$
(359)
 
 
(1)
The fair values of derivative assets and liabilities are determined based on observable market data and are considered level 2 in the fair value hierarchy. 
 
The amounts of the gains and losses related to our derivative financial instruments not designated as hedging instruments for the three and six months ended December 31, 2013 and 2012 were as follows:
 
Derivatives Not
 
Location of Gain or (Loss)
 
Amount of Gain or (Loss)
 
Designated as
 
Recognized in Earnings on
 
Recognized in Earnings on
 
Hedging Instruments
 
Derivative
 
Derivative
 
 
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
 
 
December 31,
 
December 31,
 
 
 
 
 
2013
 
2012
 
2013
 
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
Foreign currency
    forward contracts
 
Other income (expense)
 
$
(172)
 
$
(3)
 
$
583
 
$
(28)
 

8.
Long Term Debt and Credit Agreements
 
As of December 31, 2013, we were in compliance with all of the financial covenants contained in our senior secured credit facility.
 
Interest paid was $13.8 million and $18.9 million for the six months ended December 31, 2013 and 2012, respectively. Accrued interest of $2.3 million and $2.5 million was included in accrued expenses and other current liabilities at December 31, 2013 and June 30, 2013, respectively.
 
The fair value of our debt instruments was as follows:
 
 
 
As of December 31, 2013
 
 
 
(In thousands)
 
 
 
Carrying
Amount
 
Estimated Fair
Value
 
 
 
 
 
 
 
 
 
Senior secured term loan facility
 
$
587,000
 
$
591,755
 
 
As of June 30, 2013, our total debt had a carrying value of $587.0 million and an estimated fair value of $585.5 million.
 
 
11

 
The estimated fair value of our senior secured term loan facility was based on quoted prices and is considered a Level 1 measurement.

9.     Accumulated Other Comprehensive Income (Loss)
 
The changes in accumulated other comprehensive income (loss), net of tax, for the six months ended December 31, 2013 were as follows:
 
 
 
Net Minimum
Pension
Liability
 
Net
Cumulative
Translation
Adjustment
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated other comprehensive income (loss) at June 30, 2013
 
$
(1,403)
 
$
(42,003)
 
$
(43,406)
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss) before reclassifications
 
 
32
 
 
14,751
 
 
14,783
 
Amounts reclassified from accumulated other comprehensive income
 
 
18
 
 
-
 
 
18
 
Total other comprehensive income (loss)
 
 
50
 
 
14,751
 
 
14,801
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated other comprehensive income (loss) at December 31, 2013
 
$
(1,353)
 
$
(27,252)
 
$
(28,605)
 

10.     Share-Based Payment Arrangements
 
Restricted Stock Units
 
During the six months ended December 31, 2013, the compensation committee awarded restricted stock units, or RSUs, covering a total of 88,556 shares. The average grant date fair value per share of these RSUs was $7.01 and they vest in equal tranches over service periods between one and four years.

11.     Income (Loss) Per Common Share
 
Our consolidated statements of operations present basic and diluted income (loss) per common share. Basic income (loss) per common share is computed by dividing income (loss) by the weighted average number of common shares outstanding for the period. Diluted income (loss) per common share reflects the dilutive effects of RSUs and performance restricted stock units, or PRSUs, if any. The treasury stock method is used to determine the dilutive effect of these potentially dilutive securities.
 
The following table reconciles basic shares outstanding to diluted shares outstanding:
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
December 31,
 
December 31,
 
 
 
2013
 
2012
 
2013
 
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
Basic shares outstanding
 
85,014
 
84,870
 
84,965
 
84,853
 
Effect of dilution
 
209
 
10
 
-
 
-
 
 
 
 
 
 
 
 
 
 
 
Diluted shares outstanding
 
85,223
 
84,880
 
84,965
 
84,853
 
 
 
12

 
For the three and six months ended December 31, 2013, 40,000 and 957,000 shares of common stock equivalents, respectively, (which includes PRSUs that have been earned, but are subject to the continued employment of the respective participants with the Company) were excluded from the diluted weighted average shares outstanding calculation because they were anti-dilutive. Also, if all maximum performance metrics are achieved, an additional 727,000 PRSUs could potentially vest. These PRSUs have also been excluded from diluted income (loss) per common share as the performance criteria on these awards were not satisfied during these periods.
 
For the three and six months ended December 31, 2012, 1.1 million and 1.2 million shares of common stock equivalents, respectively, were excluded from the diluted weighted average shares outstanding calculation because they were anti-dilutive. Also, if all maximum performance metrics are achieved, an additional 1.1 million PRSUs could potentially vest. These PRSUs have also been excluded from diluted income (loss) per common share as the performance criteria on these awards were not satisfied during these periods.

12.     Legal Matters
 
To resolve all those outstanding violations of the Arms Export Control Act, or AECA, and the International Traffic in Arms Regulations, or ITAR, during the period from 1999 to 2009 that were disclosed by us voluntarily to the U.S. State Department concerning space related hardware items that were exported to China and, without the requisite State Department licenses, to end users in numerous other foreign countries, without admitting or denying the allegation of the violations, we have entered into a Consent Agreement effectively as of August 6, 2013, with the U.S. Department of State, Office of Defense Trade Controls Compliance. The Consent Agreement involves, among other things, a fine of $8.0 million payable over a two year period, $4.0 million of which is suspended and eligible for credit based on pre and post Consent Agreement compliance expenditures and investments made by the Company and approved by the State Department. During fiscal 2013, we recorded a charge of $8.0 million representing the legal obligation to the State Department under the then proposed terms of the Consent Agreement. In accordance with the terms of the Consent Agreement, in August 2013 we paid $2.0 million of the fine. Going forward, the Consent Agreement will not impact our ability to transact business internationally.
 
In March 2005, we sold the net assets of our shock and vibration control device manufacturing business, which we refer to as VMC. Under the terms of the sale agreements, we retained certain liabilities relating to adverse environmental conditions that existed at the premises occupied by VMC as of the date of sale. We recorded a liability for the estimated remediation costs related to adverse environmental conditions that existed at the VMC premises when it was sold. The accrued environmental liability at December 31, 2013 was $1.2 million, of which $300,000 was expected to be paid within one year.
 
We are also involved in various other claims and legal actions that arise in the ordinary course of business. We do not believe that the ultimate resolution of any of these actions will have a material adverse effect on our business, results of operations, financial position, liquidity or capital resources.

13.     Income Taxes
 
The income tax provision was $860,000 and the income tax benefit was $2.5 million for the three and six months ended December 31, 2013 on pre-tax income from continuing operations of $2.0 million and a pre-tax loss from continuing operations of $5.4 million, respectively. We recorded an income tax benefit for the three and six months ended December 31, 2012 of $5.3 million and $7.8 million on a pre-tax loss from continuing operations of $5.1 million and $22.1 million, respectively. The effective income tax rate for both periods differed from the amount computed by applying the U.S. federal income tax rate to income from continuing operations before taxes primarily due to lower foreign tax rates, and state and local income taxes, including U.S. income tax on certain foreign income that we anticipate will be repatriated to the U.S. 
 
The income tax benefit for the six months ended December 31, 2013 reflects a discrete benefit of $1.0 million relating to a reduction in the statutory income tax rate in the U.K. The income tax benefit for the six months ended December 31, 2012 reflects a discrete benefit of $252,000 relating to statutory income tax rate reductions in the U.K. and Sweden largely offset by an adjustment of estimated deferred taxes.
 
 
13

 
Absent the discrete items, the effective tax rates were 43% and 101% for the three months ended December 31, 2013 and 2012 and 29% and 34% for the six months ended December 31, 2013 and 2012, respectively. The current year’s provision was a combination of a U.S. tax benefit on a domestic book loss and a foreign tax expense on foreign book income. The prior year’s provision was a combination of a U.S. tax benefit on a domestic book loss and a foreign tax benefit on a foreign book loss.
 
In the six months ended December 31, 2013 and 2012, we paid income taxes of $12.2 million and $1.6 million and received refunds of $532,000 and $5.5 million, respectively.

14.     Business Segments
 
We are a global provider of radio frequency, or RF, and microwave integrated circuits, components and systems used in the design, development and maintenance of technically demanding, high-performance wireless communication systems. Our solutions include highly specialized microelectronic components and test and measurement equipment used by companies in the space, avionics, defense, commercial wireless communications, medical and other markets. Our sales to agencies of the United States government or to prime defense contractors or subcontractors of the United States government were approximately 30% and 26% for the three months ended December 31, 2013 and 2012 and 31% and 29% for the six months ended December 31, 2013 and 2012, respectively. No customer constituted more than 10% of sales during any of the periods presented. Inter-segment sales were not material and have been eliminated from the tables below.
 
The majority of our operations are located in the United States. We also have operations in Europe and Asia, with our most significant non-U.S. operations in the U.K. Net sales from facilities located in the U.K. were $40.8 million and $33.7 million for the three months ended December 31, 2013 and 2012 and $71.4 million and $65.5 million for the six months ended December 31, 2013 and 2012, respectively. Total assets of the U.K. operations were $211.8 million as of December 31, 2013 and $177.3 million as of June 30, 2013.
 
Net sales, based on the customers’ locations, attributed to the United States and other regions were as follows:
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
December 31,
 
December 31,
 
 
 
2013
 
2012
 
2013
 
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
United States of America
 
$
83,229
 
$
83,023
 
$
167,956
 
$
162,413
 
Europe and Middle East
 
 
29,786
 
 
25,850
 
 
49,472
 
 
58,140
 
Asia and Australia
 
 
29,412
 
 
35,699
 
 
52,893
 
 
58,249
 
Other regions
 
 
8,678
 
 
7,300
 
 
13,516
 
 
10,705
 
 
 
$
151,105
 
$
151,872
 
$
283,837
 
$
289,507
 
 
We organize our operations into two segments: Aeroflex Microelectronic Solutions, or AMS, and Aeroflex Test Solutions, or ATS. We engineer, manufacture and market a diverse range of products in each of our segments. The segment data which follows, reflects a reclassification of our frequency synthesizer product line from our ATS segment to our AMS segment for all periods presented to better align it with its end markets.  Our synthesizer reporting unit had sales of $5.4 million and $4.8 million for the three months ended December 31, 2013 and 2012 and $9.2 million and $8.4 million for the six months ended December 31, 2013, respectively.
 
 
14

 
AMS offers a broad range of microelectronics products and is a leading provider of high-performance, high reliability specialty microelectronics components. Its products include high reliability, or HiRel, microelectronics/semiconductors, RF and microwave components, mixed-signal/digital Application Specific Integrated Circuits (“ASICs”) and motion control products. ATS is a leading provider of a broad line of specialized test and measurement equipment. Its products include wireless test equipment, military radio and private mobile radio test equipment, avionics test equipment, synthetic test equipment and other general purpose test equipment.
 
Selected financial data by segment was as follows:
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
December 31,
 
December 31,
 
 
 
2013
 
2012
 
2013
 
2012
 
 
 
(In thousands)
 
Net sales
 
 
 
 
 
 
 
 
 
 
 
 
 
- Microelectronic solutions ("AMS")
 
$
83,757
 
$
83,301
 
$
157,763
 
$
161,373
 
- Test solutions ("ATS")
 
 
67,348
 
 
68,571
 
 
126,074
 
 
128,134
 
Net sales
 
$
151,105
 
$
151,872
 
$
283,837
 
$
289,507
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Segment adjusted operating income
 
 
 
 
 
 
 
 
 
 
 
 
 
- AMS
 
$
15,126
 
$
19,401
 
$
27,584
 
$
35,606
 
- ATS
 
 
8,017
 
 
5,469
 
 
10,826
 
 
6,389
 
- Corporate expense
 
 
(3,391)
 
 
(3,483)
 
 
(6,609)
 
 
(7,509)
 
Adjusted operating income
 
 
19,752
 
 
21,387
 
 
31,801
 
 
34,486
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amortization of acquired intangibles
 
 
 
 
 
 
 
 
 
 
 
 
 
- AMS
 
 
(4,480)
 
 
(8,970)
 
 
(11,204)
 
 
(17,936)
 
- ATS
 
 
(2,732)
 
 
(5,093)
 
 
(6,526)
 
 
(10,707)
 
Restructuring charges
 
 
 
 
 
 
 
 
 
 
 
 
 
- AMS
 
 
(63)
 
 
185
 
 
(68)
 
 
(19)
 
- ATS
 
 
(1,465)
 
 
(251)
 
 
(2,144)
 
 
(3,314)
 
- Corporate
 
 
(11)
 
 
-
 
 
(11)
 
 
-
 
Inventory write-off related to discontinued product line - ATS
 
 
-
 
 
-
 
 
7
 
 
-
 
Impairment of asset held for sale - AMS
 
 
-
 
 
(1,340)
 
 
-
 
 
(1,340)
 
Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
 
 
- AMS
 
 
(878)
 
 
(291)
 
 
(1,116)
 
 
(402)
 
- ATS
 
 
(121)
 
 
(126)
 
 
(352)
 
 
(193)
 
- Corporate
 
 
(131)
 
 
(314)
 
 
(544)
 
 
(772)
 
Business acquisition and divestiture related costs - Corporate
 
 
(341)
 
 
(100)
 
 
(341)
 
 
(697)
 
Current period impact of acquisition related adjustments
 
 
 
 
 
 
 
 
 
 
 
 
 
- AMS
 
 
25
 
 
20
 
 
50
 
 
11
 
- ATS
 
 
23
 
 
22
 
 
44
 
 
44
 
- Corporate
 
 
(55)
 
 
(55)
 
 
(110)
 
 
(110)
 
Operating income (loss) (GAAP)
 
 
9,523
 
 
5,074
 
 
9,486
 
 
(949)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
(7,240)
 
 
(9,768)
 
 
(14,492)
 
 
(19,846)
 
Write-off of deferred financing costs
 
 
-
 
 
(227)
 
 
-
 
 
(824)
 
Other income (expense), net
 
 
(296)
 
 
(212)
 
 
(347)
 
 
(501)
 
Income (loss) from continuing operations before income taxes
 
$
1,987
 
$
(5,133)
 
$
(5,353)
 
$
(22,120)
 
 
Management evaluates the operating results of our two segments based upon Adjusted EBITDA (as defined in our credit agreement) as well as adjusted operating income, which is pre-tax operating income before certain non-cash, non-recurring and other items. We have set out above our adjusted operating income by segment and in the aggregate, and have provided a reconciliation of adjusted operating income to operating income (loss) on a GAAP basis and income (loss) from continuing operations before income taxes for the periods presented. 
 
 
15

 
15.
Subsequent Event
 
Acquisition of Shenick Network Systems
 
On February 5, 2014, we acquired 100% of the stock of Shenick Network Systems (“Shenick”), for cash of $28.5 million. The purchase price is subject to a working capital adjustment if the adjusted net working capital at the date of closing is less than the target set forth in the purchase agreement. Shenick, located in Dublin, Ireland, is a leading edge provider of software-based wireless test solutions. Shenick will be included in our Test Solutions segment. For the calendar year 2013, Shenick had net sales of $9.4 million. On a pro forma basis, had this acquisition taken place as of the beginning of the periods presented, our results of operations for those periods would not have been materially affected.
 
 
16

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Unless the context requires otherwise:  (i) “we,” “our,” “us,” or the “Company” refer to Aeroflex Holding Corp. and subsidiaries; (ii) “fiscal” refers to the twelve months ended June 30 of the applicable year.  For example, “fiscal 2013” refers to the twelve months ended June 30, 2013.
 
Forward-Looking Statements
 
This report contains "forward-looking statements." All statements other than statements of historical fact are "forward-looking statements” for purposes of the U.S. federal and state securities laws. These statements may be identified by the use of forward looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should" or "will" or the negative thereof or other variations thereon or comparable terminology.
 
We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. A listing of some of the key factors that could cause actual results to differ from our expectations is included under the caption “Risk Factors” in our fiscal 2013 Form 10-K.
 
Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statements, either to reflect new developments, or for any other reason, except as required by law.
 
Overview
 
Company Background
 
We are a leading global provider of RF and microwave integrated circuits, components and systems used in the design, development and maintenance of technically demanding, high-performance wireless communication systems. Our solutions include highly specialized microelectronic components and test and measurement equipment used by companies in the: (i) commercial wireless communications (ii) space, avionics and defense; and (iii) medical and other markets. We have targeted customers in these end markets because we believe our solutions address their technically demanding requirements. We were founded in 1937 and have proprietary technology that is based on extensive know-how and a long history of research and development focused on specialized technologies, often in collaboration with our customers.
 
Business Segments
 
Our business segments and major products included in each segment are as follows:
 
Aeroflex Microelectronic Solutions (“AMS”) 
 
·
HiRel microelectronics/semiconductors
 
·
RF and microwave components
 
·
Mixed-signal/digital Application Specific Integrated Circuits (“ASICs”)
 
·
Motion control products
 
 
17

 
Aeroflex Test Solutions (“ATS”)
 
 
·
Wireless test equipment
 
·
Military radio and Private Mobile Radio, or PMR, test equipment
 
·
Avionics test equipment
 
·
Synthetic test equipment
 
·
General purpose test equipment
 
Discontinued Operations
 
On September 5, 2013, we sold the net assets of Aeroflex Test Equipment Services (“ATES”), a division of our U.K. subsidiary, Aeroflex Limited, for $18.4 million in cash. The consideration is subject to a working capital adjustment, based on the amount by which the final working capital at the date of closing differed from the target set forth in the purchase agreement. ATES provided calibration and repair services of non-Aeroflex test and measurement equipment in the United Kingdom and was previously included in our ATS segment. As a result of this sale, we recorded a gain on disposal of $14.1 million. The gain is not subject to U.K. taxes.   
 
We have reported the results of operations of ATES as income from discontinued operations. The prior period statement of operations has been restated to conform to the current presentation.
 
 
18

 
Results of Operations
 
The following table sets forth our historical results of operations as a percentage of net sales for the periods indicated below:
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
December 31,
 
December 31,
 
 
 
2013
 
 
2012
 
2013
 
 
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
Cost of sales
 
50.4
 
 
48.6
 
 
50.4
 
 
49.5
 
Gross profit
 
49.6
 
 
51.4
 
 
49.6
 
 
50.5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative costs
 
22.5
 
 
24.0
 
 
23.7
 
 
24.8
 
Research and development costs
 
15.0
 
 
13.9
 
 
15.6
 
 
14.5
 
Amortization of acquired intangibles
 
4.8
 
 
9.3
 
 
6.2
 
 
9.9
 
Restructuring charges
 
1.0
 
 
-
 
 
0.8
 
 
1.1
 
Impairment of asset held for sale
 
-
 
 
0.9
 
 
-
 
 
0.5
 
Total operating expenses
 
43.3
 
 
48.1
 
 
46.3
 
 
50.8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating income (loss)
 
6.3
 
 
3.3
 
 
3.3
 
 
(0.3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(4.8)
 
 
(6.4)
 
 
(5.1)
 
 
(6.8)
 
Write-off of deferred financing costs
 
-
 
 
(0.1)
 
 
-
 
 
(0.3)
 
Other income (expense), net
 
(0.2)
 
 
(0.1)
 
 
(0.1)
 
 
(0.2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations before income taxes
 
1.3
 
 
(3.3)
 
 
(1.9)
 
 
(7.6)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Provision (benefit) for income taxes
 
0.6
 
 
(3.5)
 
 
(0.9)
 
 
(2.7)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations
 
0.7
 
 
0.2
 
 
(1.0)
 
 
(4.9)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discontinued operations:
 
 
 
 
 
 
 
 
 
 
 
 
Income from discontinued operations, net of tax
 
-
 
 
0.4
 
 
0.1
 
 
0.3
 
Gain on disposal of operations, net of tax
 
-
 
 
-
 
 
5.0
 
 
-
 
Income from discontinued operations
 
-
 
 
0.4
 
 
5.1
 
 
0.3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
0.7
%
 
0.6
%
 
4.1
%
 
(4.6)
%
 
 
19

 
Three Months Ended December 31, 2013 Compared to Three Months Ended December 31, 2012
 
Net Sales.  Net sales were $151.1 million for the three months ended December 31, 2013 and $151.9 million for the three months ended December 31, 2012.
 
Net Sales
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months
 
 
 
 
% of
 
 
 
 
 
% of
 
 
 
 
 
Ended
 
 
 
 
Consolidated
 
 
 
 
 
Consolidated
 
 
 
 
 
December 31,
 
AMS
 
Net Sales
 
 
ATS
 
Net Sales
 
 
Total
 
(In thousands, except percentages)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013
 
$
83,757
 
55.4
%
 
$
67,348
 
44.6
%
 
$
151,105
 
2012
 
$
83,301
 
54.8
%
 
$
68,571
 
45.2
%
 
$
151,872
 
 
Net sales in the AMS segment increased $456,000, or 0.5%, to $83.8 million for the three months ended December 31, 2013 from $83.3 million for the three months ended December 31, 2012. This sales increase was primarily attributable to volume driven increases of HiRel microelectronics/semiconductors.
 
Net sales from continuing operations in the ATS segment decreased $1.2 million, or 1.8%, to $67.3 million for the three months ended December 31, 2013 from $68.6 million for the three months ended December 31, 2012.  A $6.1 million volume driven increase in sales of wireless test equipment was more than offset by sales volume reductions in other ATS product groups.
 
Gross Profit.  Gross profit equals net sales less cost of sales. Cost of sales includes materials, direct labor, amortization of capitalized software development costs and overhead expenses such as engineering labor, fringe benefits, depreciation, allocable occupancy costs and manufacturing supplies.
 
On a consolidated basis, gross profit was $75.0 million, or 49.6% of net sales, for the three months ended December 31, 2013 compared to $78.1 million, or 51.4% of net sales, for the three months ended December 31, 2012.  
 
Gross Profit
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months
 
 
 
 
% of
 
 
 
 
 
% of
 
 
 
 
 
% of
 
Ended
 
 
 
 
Net
 
 
 
 
 
Net
 
 
 
 
 
Net
 
December 31,
 
AMS
 
Sales
 
 
ATS
 
Sales
 
 
Total
 
Sales
 
(In thousands, except percentages)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013
 
$
37,532
 
44.8
%
 
$
37,448
 
55.6
%
 
$
74,980
 
49.6
%
2012
 
$
40,928
 
49.1
%
 
$
37,130
 
54.1
%
 
$
78,058
 
51.4
%
 
Gross margins in the AMS segment were 44.8% for the three months ended December 31, 2013 and 49.1% for the three months ended December 31, 2012. Gross profit decreased $3.4 million for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012 largely due to a reduction in the gross margins of HiRel microelectronics/semiconductors. The decrease in gross margin is primarily attributable to product mix. AMS gross profit margins are expected to improve during the second half of the fiscal year due to a combination of better mix and higher sales.
 
Gross margins in the ATS segment were 55.6% for the three months ended December 31, 2013 and 54.1% for the three months ended December 31, 2012. Gross profit increased $318,000. Gross margins improved for the three months ended December 31, 2013 as compared to the three months ended December 31, 2012, largely due to an increase in sales of our wireless test equipment, which has a higher margin than the segment average, partially offset by decreases in margins in radio test equipment primarily due to a reduction in sales.
 
 
20

  
Selling, General and Administrative Costs.  Selling, general and administrative (“SG&A”) costs include office and management salaries, fringe benefits, commissions, insurance and professional fees.
 
On a consolidated basis, SG&A costs decreased $2.4 million, or 6.6%, when comparing the three months ended December 31, 2013 to the three months ended December 31, 2012.  As a percentage of sales, SG&A decreased to 22.5% from 24.0% when comparing the three months ended December 31, 2013 to the three months ended December 31, 2012. 
 
Selling, General and Administrative Costs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months
 
 
 
 
% of
 
 
 
 
 
% of
 
 
 
 
 
 
 
 
% of
 
Ended
 
 
 
 
Net
 
 
 
 
 
Net
 
 
 
 
 
 
 
 
Net
 
December 31,
 
AMS
 
Sales
 
 
ATS
 
Sales
 
 
Corporate
 
Total
 
Sales
 
(In thousands, except percentages)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013
 
$
13,374
 
16.0
%
 
$
16,720
 
24.8
%
 
$
3,918
 
$
34,012
 
22.5
%
2012
 
$
13,084
 
15.7
%
 
$
19,391
 
28.3
%
 
$
3,952
 
$
36,427
 
24.0
%
 
In the ATS segment, SG&A costs decreased $2.7 million, primarily due to cost reduction activities in both our Wireless and AVComm groups.
 
Research and Development Costs. Research and development costs include materials, engineering labor and allocated overhead.  
 
On a consolidated basis, research and development costs increased $1.6 million for the three months ended December 31, 2013 from the three months ended December 31, 2012.  Despite reductions in sales, we continue to invest in new technologies and enhancements to support future sales.
 
Research and Development Costs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months
 
 
 
 
% of
 
 
 
 
 
% of
 
 
 
 
 
% of
 
Ended
 
 
 
 
Net
 
 
 
 
 
Net
 
 
 
 
 
Net
 
December 31,
 
AMS
 
Sales
 
 
ATS
 
Sales
 
 
Total
 
Sales
 
(In thousands, except percentages)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013
 
$
9,885
 
11.8
%
 
$
12,809
 
19.0
%
 
$
22,694
 
15.0
%
2012
 
$
8,715
 
10.5
%
 
$
12,373
 
18.0
%
 
$
21,088
 
13.9
%
  
In the AMS segment, research and development costs increased $1.2 million as a result of modest increases across all business units.
 
Amortization of Acquired Intangibles.  Amortization of acquired intangibles decreased $6.9 million due to certain intangibles becoming fully amortized during fiscal 2014.
 
Restructuring Charges.  On a consolidated basis, restructuring charges were $1.5 million for the three months ended December 31, 2013 compared to $66,000 for the three months ended December 31, 2012. For the three months ended December 31, 2013, the restructuring charges were primarily related to cost savings initiatives in the ATS segment for both our Wireless and AVComm groups, which resulted in reductions in personnel at various locations worldwide.
 
 
21

 
Impairment of Asset Held for Sale.  In December 2012, we entered into a contract for the sale of our RF and microwave components (“RFMW”) Whippany, N.J. building.  The net proceeds received in January 2013 were less than the carrying value of the building. Therefore, in December 2012, we recorded a $1.3 million impairment to the asset held for sale. Our RFMW reporting unit is included within our AMS segment.
 
Interest Expense.  Interest expense decreased by $2.5 million to $7.2 million for the three months ended December 31, 2013 from $9.8 million for the three months ended December 31, 2012. Interest expense decreased due to: (i) a lower outstanding principal amount resulting from voluntary debt payments made throughout fiscal 2013 totaling $60 million; and (ii) a 125 basis point interest rate reduction in connection with the May 29, 2013 amendment to our senior secured credit facility.
 
Income Taxes.  The income tax provision was $860,000 for the three months ended December 31, 2013 on a pre-tax income from continuing operations of $2.0 million. We recorded an income tax benefit for the three months ended December 31, 2012 of $5.3 million on a pre-tax loss from continuing operations of $5.1 million. The effective income tax rate for both periods differed from the amount computed by applying the U.S. federal income tax rate to income from continuing operations before taxes primarily due to lower foreign tax rates, and state and local income taxes, including U.S. income tax on certain foreign income that we anticipate will be repatriated to the U.S.
 
There were no discrete tax adjustments for the three months ended December 31, 2013. The income tax benefit for the three months ended December 31, 2012 reflects a discrete benefit of $136,000 relating to a statutory income tax rate reduction in Sweden.
 
Income (Loss) from Continuing Operations.  Income from continuing operations was $1.1 million for the three months ended December 31, 2013 and $173,000 for the three months ended December 31, 2012.
 
Discontinued Operations.  As a result of the sale of ATES in September 2013, its results of operations have been removed from continuing operations for all periods. Net sales from the ATES operations were $4.4 million for the three months ended December 31, 2012.
 
Net Income (Loss).  Net income (loss) was $1.1 million for the three months ended December 31, 2013 and $745,000 for the three months ended December 31, 2012.
 
Six Months Ended December 31, 2013 Compared to Six Months Ended December 31, 2012
 
Net Sales.  Net sales decreased $5.7 million, or 2.0%, to $283.8 million for the six months ended December 31, 2013 from $289.5 million for the six months ended December 31, 2012.
 
Net Sales
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months
 
 
 
 
% of
 
 
 
 
 
% of
 
 
 
 
 
Ended
 
 
 
 
Consolidated
 
 
 
 
 
Consolidated
 
 
 
 
 
December 31,
 
AMS
 
Net Sales
 
 
ATS
 
Net Sales
 
 
Total
 
(In thousands, except percentages)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013
 
$
157,763
 
55.6
%
 
$
126,074
 
44.4
%
 
$
283,837
 
2012
 
$
161,373
 
55.7
%
 
$
128,134
 
44.3
%
 
$
289,507
 

Net sales in the AMS segment decreased $3.6 million, or 2.2%, to $157.8 million for the six months ended December 31, 2013 from $161.4 million for the six months ended December 31, 2012. This sales decrease was primarily attributable to volume reductions of HiRel microelectronics/semiconductors in the first three months of the period due to government budgetary constraints that have caused delays on defense and space programs, offset in part by increased sales volume of mixed-signal/digital ASICs, which are predominantly sold to our commercial customers.
 
 
22

 
Net sales from continuing operations in the ATS segment decreased $2.1 million, or 1.6%, to $126.1 million for the six months ended December 31, 2013 from $128.1 million for the six months ended December 31, 2012. Volume driven increases in sales of wireless test equipment ($5.0 million) and avionics test equipment ($4.2 million) were more than offset by reductions in the sales volume of our radio test equipment, general purpose test equipment and synthetic test equipment.
 
Gross Profit.  On a consolidated basis, gross profit was $140.8 million, or 49.6% of net sales, for the six months ended December 31, 2013 compared to $146.3 million, or 50.5% of net sales, for the six months ended December 31, 2012. 
 
Gross Profit
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months
 
 
 
 
% of
 
 
 
 
 
% of
 
 
 
 
 
% of
 
 
Ended
 
 
 
 
Net
 
 
 
 
 
Net
 
 
 
 
 
Net
 
 
December 31,
 
AMS
 
Sales
 
 
ATS
 
Sales
 
 
Total
 
Sales
 
 
(In thousands, except percentages)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013
 
$
71,826
 
45.5
%
 
$
68,972
 
54.7
%
 
$
140,798
 
49.6
%
 
2012
 
$
78,711
 
48.8
%
 
$
67,569
 
52.7
%
 
$
146,280
 
50.5
%
 
 
Gross margins in the AMS segment were 45.5% for the six months ended December 31, 2013 and 48.8% for the six months ended December 31, 2012. Gross profit decreased $6.9 million for the six months ended December 31, 2013 as compared to the six months ended December 31, 2012 largely due to the reduction in sales, including a reduction in sales of HiRel microelectronics/semiconductors which have margins higher than the segment average. The decrease in gross margin is primarily attributable to a reduction in sales of HiRel microelectronics/semiconductors. AMS gross profit margins are expected to improve during the second half of the fiscal year due to a combination of better mix and higher sales.
 
Gross margins in the ATS segment were 54.7% for the six months ended December 31, 2013 and 52.7% for the six months ended December 31, 2012. Gross profit increased $1.4 million. Gross margins improved for the six months ended December 31, 2013 as compared to the six months ended December 31, 2012 largely due to an increase in sales of our wireless test equipment, which has a higher margin than the segment average, partially offset by decreases in margins in radio test equipment. 
 
Selling, General and Administrative Costs.  On a consolidated basis, SG&A costs decreased $4.8 million, or 6.6%, when comparing the six months ended December 31, 2013 to the six months ended December 31, 2012.  As a percentage of sales, SG&A decreased to 23.7% from 24.8% when comparing the six months ended December 31, 2013 to the six months ended December 31, 2012.
 
Selling, General and Administrative Costs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months
 
 
 
 
% of
 
 
 
 
 
% of
 
 
 
 
 
 
 
 
% of
 
 
Ended
 
 
 
 
Net
 
 
 
 
 
Net
 
 
 
 
 
 
 
 
Net
 
 
December 31,
 
 
AMS
 
Sales
 
 
 
ATS
 
Sales
 
 
 
Corporate
 
 
Total
 
Sales
 
 
(In thousands, except percentages)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013
 
$
26,201
 
16.6
%
 
$
33,375
 
26.5
%
 
$
7,604
 
$
67,180
 
23.7
%
 
2012
 
$
25,829
 
16.0
%
 
$
37,030
 
28.9
%
 
$
9,088
 
$
71,947
 
24.8
%
 
 
 
23

 
In the ATS segment, SG&A costs decreased $3.7 million, primarily due to cost reduction activities in both our Wireless and AVComm groups.
 
Corporate general and administrative costs decreased $1.5 million, primarily due to reductions in employee related expenses, acquisition related costs and legal fees.
 
Research and Development Costs. On a consolidated basis, research and development costs increased $2.2 million for the six months ended December 31, 2013 from the six months ended December 31, 2012.  Despite reductions in sales, we continue to invest in new technologies and enhancements to support future sales. 
 
Research and Development Costs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months
 
 
 
 
% of
 
 
 
 
 
% of
 
 
 
 
 
% of
 
 
Ended
 
 
 
 
Net
 
 
 
 
 
Net
 
 
 
 
 
Net
 
 
December 31,
 
AMS
 
Sales
 
 
ATS
 
Sales
 
 
Total
 
Sales
 
 
(In thousands, except percentages)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2013
 
$
19,108
 
12.1
%
 
$
25,071
 
19.9
%
 
$
44,179
 
15.6
%
 
2012
 
$
17,667
 
10.9
%
 
$
24,299
 
19.0
%
 
$
41,966
 
14.5
%
 
 
In the AMS segment, research and development costs increased $1.4 million as a result of modest increases across all business units.
 
In the ATS segment, research and development costs increased $772,000 primarily due to increased costs for the development of wireless products.
 
Amortization of Acquired Intangibles.  Amortization of acquired intangibles decreased $10.9 million due to certain intangibles becoming fully amortized during fiscal 2014.
 
Restructuring Charges.  On a consolidated basis, restructuring charges were $2.2 million for the six months ended December 31, 2013 compared to $3.3 million for the six months ended December 31, 2012. For both of the six month periods ended December 31, 2013 and 2012, the restructuring charges were primarily related to cost savings initiatives in the ATS segment for both our Wireless and AVComm groups, which resulted in reductions in personnel at various locations worldwide.
 
Impairment of Asset Held for Sale.  In December 2012, we entered into a contract for the sale of our RFMW Whippany, N.J. building. The net proceeds received in January 2013 were less than the carrying value of the building. Therefore, in December 2012, we recorded a $1.3 million impairment to the asset held for sale. Our RFMW reporting unit is included within our AMS segment.
 
Interest Expense.  Interest expense decreased by $5.4 million to $14.5 million for the six months ended December 31, 2013 from $19.8 million for the six months ended December 31, 2012. Interest expense decreased due to: (i) a lower outstanding principal amount resulting from voluntary debt payments made throughout fiscal 2013 totaling $60 million; and (ii) a 125 basis point interest rate reduction in connection with the May 29, 2013 amendment to our senior secured credit facility.
 
Income Taxes.  The income tax benefit was $2.5 million for the six months ended December 31, 2013 on a pre-tax loss from continuing operations of $5.4 million. We recorded an income tax benefit for the six months ended December 31, 2012 of $7.8 million on a pre-tax loss from continuing operations of $22.1 million. The effective income tax rate for both periods differed from the amount computed by applying the U.S. federal income tax rate to income from continuing operations before taxes primarily due to lower foreign tax rates, and state and local income taxes, including U.S. income tax on certain foreign income that we anticipate will be repatriated to the U.S. 
 
 
24

 
The income tax benefit for the six months ended December 31, 2013 reflects a discrete benefit of $1.0 million relating to a reduction in the statutory income tax rate in the U.K. The income tax benefit for the six months ended December 31, 2012 reflects a discrete benefit of $252,000 relating to statutory income tax rate reductions in the U.K. and Sweden largely offset by an adjustment of estimated deferred taxes.
 
Income (Loss) from Continuing Operations.  Loss from continuing operations was $(2.8) million for the six months ended December 31, 2013 and $(14.3) million for the six months ended December 31, 2012.
 
Discontinued Operations.  As a result of the sale of ATES in September 2013, its results of operations have been removed from continuing operations for all periods. Net sales from the ATES operations were $2.4 million from July 1, 2013 to the date of sale and $7.9 million for the six months ended December 31, 2012. The gain on disposal was $14.1 million.
 
Net Income (Loss).  Net income (loss) was $11.6 million for the six months ended December 31, 2013 and $(13.4) million for the six months ended December 31, 2012. 
 
Liquidity and Capital Resources
 
As of December 31, 2013, we had $60.9 million of cash and cash equivalents, $297.3 million in working capital and our current ratio was 3.76 to 1, versus $39.4 million, $262.8 million and 3.04 to 1, respectively, at June 30, 2013. 
 
Our principal liquidity requirements are to service our debt and interest and meet our working capital and capital expenditure needs. As of December 31, 2013, we had $587.0 million of debt outstanding, all of which was long-term, under our senior secured term loan facility.  Additionally, at December 31, 2013, we were able to borrow $57.1 million under the revolving portion of our senior secured credit facility, of which none was outstanding.
 
The financial covenant was eliminated from the term loan portion of our senior secured credit facility, when it was amended on May 29, 2013. To the extent that, at a quarter end, we have outstanding borrowings under the revolving credit portion of our senior secured term loan facility, we would be subject to a financial covenant based on Adjusted EBITDA. Adjusted EBITDA is defined as EBITDA (net income (loss) before interest expense, income taxes, depreciation and amortization), adjusted to add back or subtract  certain non-cash, non-recurring and other items, as permitted by our senior secured credit facility. Our use of the term Adjusted EBITDA may vary from others in our industry.  EBITDA and Adjusted EBITDA are not measures of operating income (loss), performance or liquidity under U.S. GAAP and are subject to important limitations.  A reconciliation of net income (loss), which is a U.S. GAAP measure of our operating results, to Adjusted EBITDA, as defined in our debt agreement, is as follows: 
 
 
25

 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
December 31,
 
December 31,
 
 
 
2013
 
2012
 
2013
 
2012
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
$
1,127
 
$
745
 
$
11,634
 
$
(13,394)
 
Income from discontinued operations
 
 
-
 
 
(572)
 
 
(14,462)
 
 
(949)
 
Income (loss) from continuing operations
 
 
1,127
 
 
173
 
 
(2,828)
 
 
(14,343)
 
Interest expense
 
 
7,240
 
 
9,768
 
 
14,492
 
 
19,846
 
Provision (benefit) for income taxes
 
 
860
 
 
(5,306)
 
 
(2,525)
 
 
(7,777)
 
Depreciation and amortization
 
 
13,313
 
 
19,564
 
 
29,762
 
 
39,687
 
EBITDA
 
 
22,540
 
 
24,199
 
 
38,901
 
 
37,413
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restructuring related costs, including pro forma savings(a)
 
 
1,797
 
 
811
 
 
3,052
 
 
5,419
 
Impairment of asset held for sale
 
 
-
 
 
1,340
 
 
-
 
 
1,340
 
Share-based compensation
 
 
1,130
 
 
731
 
 
2,012
 
 
1,367
 
Write-off of deferred financing costs
 
 
-
 
 
227
 
 
-
 
 
824
 
Other defined items(b)
 
 
604
 
 
137
 
 
618
 
 
934
 
Adjusted EBITDA
 
$
26,071
 
$
27,445
 
$
44,583
 
$
47,297
 
 
(a) Primarily reflects costs associated with the reorganization of our European operations and consolidation of certain of our U.S. operations. Pro forma savings reflect the costs that we estimate would have been eliminated during the fiscal year in which a restructuring occurred had the restructuring occurred as of the first day of that fiscal year.  Pro forma savings were estimated to be $258,000 and $745,000 for the three months ended December 31, 2013 and 2012 and $829,000 and $2.1 million for the six months ended December 31, 2013 and 2012, respectively. The pro forma savings for the three months and six months ended December 31, 2012 includes an additional $745,000 and $1.7 million which was not reflected in our Adjusted EBITDA as reported in our December 31, 2012 report on Form 10-Q as it relates to restructuring activities recorded throughout fiscal 2013.
 
(b) Reflects other adjustments required in calculating our debt covenant compliance. These other defined items include legal fees related to certain litigation and business acquisition and divestiture related costs.
 
The maximum leverage ratio of total debt (less up to $15.0 million of unrestricted cash) to Adjusted EBITDA, as defined in our senior secured credit facility, as amended, is only in effect if as of the last day of the fiscal quarter there are any outstanding borrowings under our senior secured revolving credit facility. The maximum leverage ratio permitted for the twelve months ended December 31, 2013 was 5.50, whereas our actual leverage ratio was 4.61.
 
As of December 31, 2013, there were no outstanding amounts under our senior secured revolving credit facility, therefore, the maximum leverage ratio covenant was not applicable. As of December 31, 2013, we were in compliance with all of the covenants contained in our senior secured credit facility.
 
Our senior secured credit facility contains restrictions on our activities, including but not limited to covenants that restrict us and our restricted subsidiaries, as defined in our senior secured credit facility, from: 
 
 
·
incurring additional indebtedness and issuing disqualified stock or preferred stock;
 
 
 
 
·
making certain investments or other restricted payments;
 
 
 
 
·
paying dividends and making other distributions with respect to capital stock, or repurchasing, redeeming or retiring capital stock or subordinated debt;
 
 
26

  
 
·
selling or otherwise disposing of assets;
 
 
 
 
·
under certain circumstances, issuing or selling equity interests;
 
 
 
 
·
creating liens on our assets;
 
 
 
 
·
consolidating or merging with, or acquiring in excess of specified annual limitations, another business, or selling or disposing of all or substantially all of our assets; and
 
 
 
 
·
entering into certain transactions with our affiliates.
 
If for any reason we fail to comply with the covenants in the senior secured credit facility, we would be in default under the terms of the agreements governing our outstanding debt. If such a default were to occur, the lenders under the senior secured credit facility could elect to declare all amounts outstanding thereunder immediately due and payable, and the lenders would not be obligated to continue to advance funds to us. If the amounts outstanding under these debt agreements are accelerated, our assets may not be sufficient to repay in full the amounts owed.
 
We expect that cash generated from operating activities and availability under the revolving portion of our senior secured credit facility will be our principal sources of liquidity. Our ability to make payments on and to refinance our indebtedness and to fund working capital needs and planned capital expenditures will depend on our ability to generate cash in the future. This, to a certain extent, is subject to general economic, financial, competitive and other factors that are beyond our control. In addition, to the extent we have consolidated excess cash flows, as defined in the credit agreement governing the senior secured credit facility, we must use specified portions of the excess cash flows to prepay the senior secured credit facility. Based on our current level of operations, we believe our cash flow from operations and available borrowings under our senior secured credit facility will be adequate to meet our liquidity needs for at least the next twelve months. We cannot assure you, however, that our business will generate sufficient cash flow from operations, or those future borrowings will be available under the senior secured credit facility in an amount sufficient to enable us to repay our indebtedness at maturity or to fund other liquidity needs. We may need to refinance all or a portion of our indebtedness on or before the maturity thereof. We cannot assure you that we will be able to refinance any of our indebtedness on commercially reasonable terms or at all.
 
Cash Flows
 
For the six months ended December 31, 2013, our cash flow provided by operations was $10.0 million.  Our investing activities provided cash of $8.9 million, primarily due to $18.4 million of proceeds from the sale of ATES, partially offset by capital expenditures of $9.7 million. Our financing activities used cash of $1.8 million.
 
For the six months ended December 31, 2012, our cash flow provided by operations was $44.1 million, which included cash generated by reductions in accounts receivable of $20.4 million.  Our investing activities used cash of $8.9 million, primarily for capital expenditures of $9.3 million. Our financing activities used cash of $35.6 million, primarily for voluntary debt prepayments of $35.0 million. 
 
The decrease of $34.1 million in cash provided by operating activities when comparing the six months ended December 31, 2013 to the six months ended December 31, 2012, resulted primarily from a current year increase in inventory of $11.7 million, to support a sales ramp expected in the latter part of the fiscal year, increased income tax payments of $10.6 million and decreased accounts payable and accrued expenses of $11.9 million primarily due to timing of payments.
 
 
27

 
Capital Expenditures
 
Capital expenditures were $9.7 million and $9.3 million for the six months ended December 31, 2013 and 2012, respectively.  Our capital expenditures consist primarily of equipment replacements. 
 
Contractual Obligations
 
There have been no material changes in our contractual obligations as disclosed in our fiscal 2013 Form    10-K.
 
Off-Balance Sheet Arrangements
 
We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have material current or future effect upon our results of operations or financial condition.
 
Critical Accounting Policies and Estimates
 
Information regarding our critical accounting policies and estimates appears within the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our fiscal 2013 Form 10-K.  During the six month period ended December 31, 2013, there were no significant changes to any critical accounting policies or to the related estimates and judgments involved in applying those policies.
 
Recent Accounting Pronouncements 
 
For information with respect to recent accounting pronouncements and the impact of these pronouncements on our consolidated financial statements, see Note 2 of Notes to Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report.
 
 
28

 

ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 
Interest Rate Risk.  We are subject to interest rate risk in connection with borrowings under our senior secured credit facility, including any outstanding borrowings under our revolving credit facility.  We currently do not have interest rate swap agreements hedging this debt. As of December 31, 2013, $587.0 million was outstanding under the term-loan portion of the senior secured credit facility, bearing interest at 4.50% based on the adjusted LIBOR rate, which consists of a floor of 100 basis points, plus an applicable margin of 350 basis points above the floor. Our outstanding debt balance is subject to variable interest rates dependent upon fluctuations of the LIBOR rate.  Based on the LIBOR rate at December 31, 2013, which was .25%, an increase of 1% in interest rates would only result in a .25% increase on the interest rate relating to our outstanding borrowings due to the 1.00% LIBOR floor, or a $1.5 million increase in our annual interest expense. An increase of 1% in the LIBOR rate above the 1.00% floor would result in a $6.0 million increase in our annual interest expense. In addition, as of December 31, 2013, our revolving credit facility of $57.1 million, which would bear interest at 3.75% based on the LIBOR rate of .25% plus 350 basis points, was undrawn. Assuming the entire amount available to us was outstanding, a 1% change in interest rates would result in a $579,000 change in our annual interest expense. Any debt we incur in the future may also bear interest at floating rates.
 
Foreign Currency Risk.  Foreign currency contracts are used to protect us from exchange rate fluctuation from the time customers are invoiced in local currency until such currency is exchanged for U.S. dollars. We periodically enter into foreign currency contracts, which are not designated as hedges, and the change in the fair value is included in income currently within other income (expense). As of December 31, 2013, we had $47.8 million of notional value foreign currency forward contracts maturing through January 31, 2014. Notional amounts do not quantify risk or represent assets or liabilities, but are used in the calculation of cash settlements under the contracts. The fair value of these contracts at December 31, 2013 was an asset of $224,000. If foreign currency exchange rates (primarily the British pound and the Euro) change by 10% from the levels at December 31, 2013, the effect on our comprehensive income would be approximately $19.8 million.
  
Inflation Risk.  Inflation has not had a material impact on our results of operations or financial condition during the preceding three years.
 

ITEM 4.   CONTROLS AND PROCEDURES

 
Our disclosure controls and procedures under the Securities Exchange Act of 1934, as amended, are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities and Exchange Commission. Our disclosure controls and procedures are also designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Our Principal Executive Officer and our Principal Financial Officer, with the assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of December 31, 2013 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.
 
There have been no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 
 
 
29

 
PART II – OTHER INFORMATION
 

Item 1.     Legal Proceedings

 
There have been no material changes in our legal proceedings disclosed in our fiscal 2013 Form 10-K.
 

Item 1A.   Risk Factors

 
There have been no material changes in our risk factors disclosed in our fiscal 2013 Form 10-K.

 

Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds

 
None

 

Item 3.     Defaults upon Senior Securities

 
None

 

Item 4.     Mine Safety Disclosures

 

Not applicable

 

Item 5.     Other Information

 
On February 6, 2014, the Board of Directors approved amendments to the Amended and Restated Employment Agreements of Leonard Borow, our Chief Executive Officer, and John E. Buyko, our Executive Vice President, which provide that in the event their employment is terminated without cause or for “good reason” in either case within 6 months prior to, or 18 months after, a Change in Control (as defined therein), they will receive, without duplication, in addition to all of the benefits to which they currently are entitled if their employment is terminated without cause, two times their Base Salary and two times their Target Bonus, payable over the remainder of the term of their employment agreement.
 
The foregoing is a brief description of the amendments and does not purport to be complete.  Reference is made to the amendments, as reflected in the Amended and Restated Employment Agreements, dated February 6, 2014, for a full description of their terms, copies of which are attached hereto as Exhibits 10.1 and 10.2 and incorporated herein by reference.
 
Item 6.      Exhibits
 
See index of exhibits included on page 32.
 
 
30

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
AEROFLEX HOLDING CORP.
 
 
 
/s/ John Adamovich, Jr.
 
John Adamovich, Jr.
 
Senior Vice President and
 
Chief Financial Officer
 
(Principal Financial Officer)
February 7, 2014
 
 
 
31

 
EXHIBIT INDEX
 
Exhibit No.
 
Exhibit Description
 
 
 
10.1
 
Amended and Restated Employment Agreement between Aeroflex Incorporated and Leonard Borow, dated February 6, 2014.
 
 
 
10.2
 
Amended and Restated Employment Agreement between Aeroflex Incorporated and John E. Buyko, dated February 6, 2014.
 
 
 
31.1
 
Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)
 
 
 
31.2
 
Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)
 
 
 
31.3
 
Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Principal Accounting Officer)
 
 
 
32.1
 
Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)
 
 
 
32.2
 
Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)
 
 
 
101.INS
 
XBRL Instance Document
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
32